TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Skandinavisk BioTech AB
Closing information (x1000 DKK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
3,839
|
3,762
|
4,237 |
| Financial expenses |
4
|
2
|
1 |
| Earnings before taxes |
1,000
|
517
|
673 |
| EBITDA |
925
|
452
|
666 |
| Total assets |
3,716
|
6,050
|
6,109 |
| Current assets |
2,674
|
4,503
|
4,565 |
| Current liabilities |
2,237
|
632
|
630 |
| Equity capital |
1,480
|
4,996
|
5,080 |
| - share capital |
66
|
63
|
70 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
39.8%
|
82.6%
|
83.2% |
| Turnover per employee |
3,839
|
3,762
|
4,237 |
| Profit as a percentage of turnover |
26.0%
|
13.7%
|
15.9% |
| Return on assets (ROA) |
27.0%
|
8.6%
|
11.0% |
| Current ratio |
119.5%
|
712.5%
|
724.6% |
| Return on equity (ROE) |
67.6%
|
10.3%
|
13.2% |
| Change turnover |
-95
|
-67
|
1,441 |
| Change turnover % |
-2%
|
-2%
|
52% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.